• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,763.91 261.79
( 0.34%)
Global Indices
Nasdaq
52,921.07 594.83
(1.14%)
Dow Jones
7,504.24 0.01
(0.00%)
Hang Seng
69,733.68 1,000.53
(1.46%)
Nikkei 225
10,673.34 20.47
(0.19%)
Forex
USD-INR
95.28 0.28
(0.30%)
EUR-INR
108.75 0.54
(0.50%)
GBP-INR
126.99 1.06
(0.84%)
JPY-INR
0.59 0.01
(0.97%)

EQUITY - MARKET SCREENER

Cohance Lifesciences Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543064
INE03QK01018
117.1064173
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
COHANCE
69.55
17401.07
EPS(TTM)
Face Value()
Div & Yield %
6.54
1
0
 

Axtel Industries rises after Q3 PAT spurts 145% YoY to Rs 8 cr
Feb 03,2026
Net sales jumped 45.09% year-over-year (YoY) to Rs 58.63 crore during the quarter. Profit before tax in Q3 FY26 stood at Rs 10.83 crore, up by 118.35% from Rs 4.96 crore in Q3 FY25.

Total operating expenditure rose by 34.83% to Rs 49.24 crore in Q3 FY26. The cost of material consumed was at Rs 22.85 crore (up 41.08% YoY), employee benefit expense stood at Rs 11.14 crore (up 7.43% YoY), and other expense was at Rs 10.84 crore (up 57.56% YoY) during the period under review.

Axtel Industries (AIL) manufactures custom-designed food processing plants and machinery tailored to clients’ requirements.